We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+24.59%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.9B
AUM Growth
+$12.2B
(+25%)
Cap. Flow
+$2B
Cap. Flow
% of AUM
3.34%
Top 10 Holdings %
Top 10 Hldgs %
21.63%
Holding
3,213
New
281
Increased
1,628
Reduced
1,147
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$134M |
| 2 |
Microsoft
MSFT
|
+$119M |
| 3 |
Apple
AAPL
|
+$87.6M |
| 4 |
AbbVie
ABBV
|
+$61.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$92.9M |
| 2 |
RTN
Raytheon Company
RTN
|
+$71.6M |
| 3 |
CY
Cypress Semiconductor
CY
|
+$23.6M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$12.9M |
| 5 |
Domino's
DPZ
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.43% |
| 2 | Healthcare | 14.28% |
| 3 | Financials | 13.11% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Communication Services | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Ring Energy
REI
$339M
| $101K | ﹤0.01% |
87,361
-105,529
| -55% | -$103K |
|
2952
Mustang Bio
MBIO
$4.55M
| $100K | ﹤0.01% |
42
+3
| +8% | +$7.01K |
|
2953
Enel Chile
ENIC
$6.28B
| $99K | ﹤0.01% |
+26,230
| New | +$99.3K |
|
2954
Harrow
HROW
$1.51B
| $99K | ﹤0.01% |
+18,949
| New | +$93.1K |
|
2955
iBio
IBIO
$70M
| $99K | ﹤0.01% |
+89
| New | +$58.2K |
|
2956
Intellicheck
IDN
$79.6M
| $98K | ﹤0.01% |
+12,991
| New | +$78.8K |
|
2957
Cibus
CBUS
$138M
| $97K | ﹤0.01% |
394
+188
| +91% | +$42.1K |
|
2958
Galectin Therapeutics
GALT
$348M
| $97K | ﹤0.01% |
31,799
+1,001
| +3% | +$2.52K |
|
|
ESTE
2959
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $97K | ﹤0.01% |
34,283
+4,705
| +16% | +$11.5K |
|
2960
Genie Energy
GNE
$383M
| $93K | ﹤0.01% |
12,699
-2,201
| -15% | -$17.3K |
|
|
RESN
2961
DELISTED
Resonant Inc.
RESN
| $93K | ﹤0.01% |
+39,901
| New | +$88.6K |
|
|
GDP
2962
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
| $91K | ﹤0.01% |
12,680
-2,147
| -14% | -$15.2K |
|
2963
Barnes & Noble Education
BNED
$443M
| $90K | ﹤0.01% |
564
-816
| -59% | -$132K |
|
2964
Retractable Technologies
RVP
$20.1M
| $89K | ﹤0.01% |
+12,663
| New | +$58.6K |
|
|
EVLO
2965
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $87K | ﹤0.01% |
889
-127
| -13% | -$11.1K |
|
2966
Research Frontiers
REFR
$17M
| $85K | ﹤0.01% |
+20,985
| New | +$77.8K |
|
2967
VolitionRx Ltd
VNRX
$9.34M
| $85K | ﹤0.01% |
+1,098
| New | +$79.3K |
|
|
TCS
2968
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $85K | ﹤0.01% |
1,759
+116
| +7% | +$4.48K |
|
|
ALR
2969
DELISTED
AlerisLife Inc
ALR
| $85K | ﹤0.01% |
+21,820
| New | +$77.8K |
|
|
PFSW
2970
DELISTED
PFSweb, Inc.
PFSW
| $84K | ﹤0.01% |
+12,515
| New | +$66.4K |
|
2971
Aquestive Therapeutics
AQST
$494M
| $83K | ﹤0.01% |
+17,040
| New | +$78.4K |
|
2972
Genprex
GNPX
$2.16M
| $83K | ﹤0.01% |
+1
| New | +$122K |
|
2973
Ultralife
ULBI
$106M
| $80K | ﹤0.01% |
+11,449
| New | +$83.7K |
|
|
SMED
2974
DELISTED
Sharps Compliance Corp
SMED
| $79K | ﹤0.01% |
+11,285
| New | +$80.2K |
|
2975
Beyond Air
XAIR
$3.86M
| $78K | ﹤0.01% |
+27
| New | +$83.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2020 Portfolio in Review
As of Q2 2020, RhumbLine Advisers held 3,213 positions worth $59.9B, up 25% from $47.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers deployed $2B of net new capital in Q2 2020, opening 281 new positions and adding to 1,628 existing holdings. Its largest new stake was Otis Worldwide: 701,378 shares worth $39.9M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $12.9M trimmed.
- RhumbLine Advisers's largest Q2 2020 buy was Otis Worldwide: 701,378 shares worth $39.9M.
- RhumbLine Advisers added most to Amazon in Q2 2020, an estimated $134M increase.
- RhumbLine Advisers's biggest Q2 2020 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $12.9M.
- RhumbLine Advisers fully exited Allergan plc in Q2 2020, selling an estimated $92.9M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $59.9B portfolio in Q2 2020.
- RhumbLine Advisers opened 281 new positions and closed 147 in Q2 2020.
- RhumbLine Advisers's portfolio value rose 25% quarter-over-quarter to $59.9B.
Based on RhumbLine Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.